Psychedelics Weekly – AIMS vs. the DEA: An Update on the Fight to Reschedule Psilocybin

<p dir="ltr">In this episode, David is joined by Director of Advocacy at the National Psychedelics Association, Kathryn L. Tucker, JD, who updates us on the 3 AIMS vs. the DEA cases, discussing what their outcome could mean for the future.</p> <p dir="ltr">www.psychedelicstoday.com</p> <p> </p>